Inhibition of nuclear hormone receptor activity by calreticulin. Dedhar S, Rennie PS, Shago M, Hagesteijn CY, Yang H, Filmus J, Hawley RG, Bruchovsky N, Cheng H, Matusik RJ (1994) Nature 367: 480-3 Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Gilchuk P, Kuzmina N, Ilinykh PA, Huang K, Gunn BM, Bryan A, Davidson E, Doranz BJ, Turner HL, Fusco ML, Bramble MS, Hoff NA, Binshtein E, Kose N, Flyak AI, Flinko R, Orlandi C, Carnahan R, Parrish EH, Sevy AM, Bombardi RG, Singh PK, Mukadi P, Muyembe-Tamfum JJ, Ohi MD, Saphire EO, Lewis GK, Alter G, Ward AB, Rimoin AW, Bukreyev A, Crowe JE (2018) Immunity 49: 363-374.e10 Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge. Zhao H, Xu L, Bombardi R, Nargi R, Deng Z, Errico JM, Nelson CA, Dowd KA, Pierson TC, Crowe JE, Diamond MS, Fremont DH (2020) J Exp Med 217: The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding. King LB, Fusco ML, Flyak AI, Ilinykh PA, Huang K, Gunn B, Kirchdoerfer RN, Hastie KM, Sangha AK, Meiler J, Alter G, Bukreyev A, Crowe JE, Saphire EO (2018) Cell Host Microbe 23: 101-109.e4 A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Fibriansah G, Tan JL, Smith SA, de Alwis R, Ng TS, Kostyuchenko VA, Jadi RS, Kukkaro P, de Silva AM, Crowe JE, Lok SM (2015) Nat Commun 6: 6341 Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Yount B, Curtis KM, Fritz EA, Hensley LE, Jahrling PB, Prentice E, Denison MR, Geisbert TW, Baric RS (2003) Proc Natl Acad Sci U S A 100: 12995-3000 Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. de Alwis R, Smith SA, Olivarez NP, Messer WB, Huynh JP, Wahala WM, White LJ, Diamond MS, Baric RS, Crowe JE, de Silva AM (2012) Proc Natl Acad Sci U S A 109: 7439-44 Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Becker MM, Graham RL, Donaldson EF, Rockx B, Sims AC, Sheahan T, Pickles RJ, Corti D, Johnston RE, Baric RS, Denison MR (2008) Proc Natl Acad Sci U S A 105: 19944-9 Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. Lifland AW, Jung J, Alonas E, Zurla C, Crowe JE, Santangelo PJ (2012) J Virol 86: 8245-58 Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins. Prentice E, McAuliffe J, Lu X, Subbarao K, Denison MR (2004) J Virol 78: 9977-86 Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice. Luque LE, Bridges OA, Mason JN, Boyd KL, Portner A, Russell CJ (2010) J Virol 84: 810-21 A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization. Silva LA, Khomandiak S, Ashbrook AW, Weller R, Heise MT, Morrison TE, Dermody TS (2014) J Virol 88: 2385-97 ATR and ATRIP are recruited to herpes simplex virus type 1 replication compartments even though ATR signaling is disabled. Mohni KN, Livingston CM, Cortez D, Weller SK (2010) J Virol 84: 12152-64 Serotonin Receptor Agonist 5-Nonyloxytryptamine Alters the Kinetics of Reovirus Cell Entry. Mainou BA, Ashbrook AW, Smith EC, Dorset DC, Denison MR, Dermody TS (2015) J Virol 89: 8701-12 Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies. Ilinykh PA, Shen X, Flyak AI, Kuzmina N, Ksiazek TG, Crowe JE, Bukreyev A (2016) J Virol 90: 3890-3901 Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity. Whitehead SS, Firestone CY, Karron RA, Crowe JE, Elkins WR, Collins PL, Murphy BR (1999) J Virol 73: 871-7 SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. Huang IC, Bosch BJ, Li F, Li W, Lee KH, Ghiran S, Vasilieva N, Dermody TS, Harrison SC, Dormitzer PR, Farzan M, Rottier PJ, Choe H (2006) J Biol Chem 281: 3198-203 Identification of toxemia in patients with Clostridium difficile infection. Yu H, Chen K, Wu J, Yang Z, Shi L, Barlow LL, Aronoff DM, Garey KW, Savidge TC, von Rosenvinge EC, Kelly CP, Feng H (2015) PLoS One 10: e0124235 Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1β Secretion: A Primary Human Monocyte Model. Callaway JB, Smith SA, Widman DG, McKinnon KP, Scholle F, Sempowski GD, Dittmer DP, Crowe JE, de Silva AM, Ting JP (2015) PLoS One 10: e0136708 Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. Crowe JE, Bui PT, Siber GR, Elkins WR, Chanock RM, Murphy BR (1995) Vaccine 13: 847-55 Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus. Hsu KH, Crowe JE, Lubeck MD, Davis AR, Hung PP, Chanock RM, Murphy BR (1995) Vaccine 13: 509-15 Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis. Crowe JE, Bui PT, London WT, Davis AR, Hung PP, Chanock RM, Murphy BR (1994) Vaccine 12: 691-9 A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees. Crowe JE, Bui PT, Davis AR, Chanock RM, Murphy BR (1994) Vaccine 12: 783-90 Characterization of dengue virus 2 growth in megakaryocyte-erythrocyte progenitor cells. Clark KB, Hsiao HM, Bassit L, Crowe JE, Schinazi RF, Perng GC, Villinger F (2016) Virology 493: 162-72 A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. McClain MS, Cao P, Iwamoto H, Vinion-Dubiel AD, Szabo G, Shao Z, Cover TL (2001) J Bacteriol 183: 6499-508 SARS coronavirus replicase proteins in pathogenesis. Graham RL, Sparks JS, Eckerle LD, Sims AC, Denison MR (2008) Virus Res 133: 88-100 Acquisition of the ts phenotype by a chemically mutagenized cold-passaged human respiratory syncytial virus vaccine candidate results from the acquisition of a single mutation in the polymerase (L) gene. Crowe JE, Firestone CY, Whitehead SS, Collins PL, Murphy BR (1996) Virus Genes 13: 269-73
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.